Cite
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.
MLA
Kochat, Veena, et al. “Enhancer Reprogramming in PRC2-Deficient Malignant Peripheral Nerve Sheath Tumors Induces a Targetable de-Differentiated State.” Acta Neuropathologica, vol. 142, no. 3, Sept. 2021, pp. 565–90. EBSCOhost, https://doi.org/10.1007/s00401-021-02341-z.
APA
Kochat, V., Raman, A. T., Landers, S. M., Tang, M., Schulz, J., Terranova, C., Landry, J. P., Bhalla, A. D., Beird, H. C., Wu, C.-C., Jiang, Y., Mao, X., Lazcano, R., Gite, S., Ingram, D. R., Yi, M., Zhang, J., Keung, E. Z., Scally, C. P., … Torres, K. E. (2021). Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathologica, 142(3), 565–590. https://doi.org/10.1007/s00401-021-02341-z
Chicago
Kochat, Veena, Ayush T Raman, Sharon M Landers, Ming Tang, Jonathan Schulz, Christopher Terranova, Jace P Landry, et al. 2021. “Enhancer Reprogramming in PRC2-Deficient Malignant Peripheral Nerve Sheath Tumors Induces a Targetable de-Differentiated State.” Acta Neuropathologica 142 (3): 565–90. doi:10.1007/s00401-021-02341-z.